Investor Presentaiton

We Took Decisive Actions to Protect the Company During the Pandemic and Position It for Growth Thereafter Took necessary actions in 2020 to manage our business through a once-in-a-lifetime crisis in the senior housing industry... Dividend Reduction G&A Rationalization ■ Cut our dividend by 43% in June 2020 ■ Reduction in quarterly payout from $0.7925 to $0.45 preserved $130M in capital per quarter Today have the strongest dividend coverage among peers CapEx Reductions ■ In June 2020, carried out reduction in force affecting over 25% of corporate positions ■ Reduced executive base salaries by 10-20% in 2020 Savings of $30M in SG&A expense vs. 2019 baseline ...and in 2021 to position our business to participate in the powerful industry recovery now NNN Lease Restructurings Accessed the Debt Markets ■ Addressed ~90% of pre-pandemic senior housing NNN NOI through transitions, asset sales and lease reductions ■ Most notably, in July 2020 announced mutually agreeable lease modification with our largest tenant Brookdale, receiving $235M in consideration and upside benefits ■ To manage interest rate risk, Ventas raised over $1.1B in new bonds in the U.S. and Canada Including a 10-year offering with a coupon of 2.5%, the best 10-year healthcare REIT issuance in 2021 Issued $1.4B of equity in 2021 underway Raised Equity ■ Includes $0.6B under at-the-market equity offering program and $0.8B to shareholders of New Senior Investment Group, which we acquired in September 2021 Accessed the Debt Markets GIC Joint Venture Capital Recycling GIC Joint Venture Av VENTASⓇ ■ Proactively reduced 2020 capital expenditures by $0.3B to ~$0.5B, much of which was funded with committed financing ■ Raised $0.5B of senior notes and drew down revolving credit facility early in the pandemic ■ Credit facility was paid down in summer 2020 as capital markets stabilized ■ Announced in Nov. 2020 a joint venture with GIC, with Ventas contributing a $930M Research & Innovation development pipeline and GIC taking a 45% interest ■ ■ Structure increases diversification of capital sources while preserving majority ownership and upside participation In 2021, booked $1.2B in asset dispositions and loan repayments, enhancing our portfolio quality ■ Used proceeds to reduce near-term maturities by $1.1B ■ Continued to use our GIC joint venture to accelerate investment in value-creating Life Science investments ■ Numerous projects under development, including marquee $0.5B UC Davis project 10

View entire presentation